Atorvastatin

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Atorvastatin and local guidelines before prescribing.

Statin (HMG-CoA reductase inhibitor)

Mechanism

HMG-CoA reductase inhibitor lowering hepatic cholesterol synthesis and increasing LDL receptors.

Uses

Primary and secondary cardiovascular prevention, hypercholesterolaemia.

Dosing

4 more dose entries from the chapters

Side effects

Myalgia, raised ALT, GI upset; rarely myopathy, rhabdomyolysis, new-onset diabetes.

Interactions

Clarithromycin, azole antifungals and ciclosporin raise levels; grapefruit juice in large amounts; fibrates increase myopathy risk.

Contraindications and cautions

Active liver disease; caution in alcohol excess

Monitoring

Lipids, ALT at baseline and 3 months, CK if symptoms

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

No renal adjustment

Overdose and reversal

Supportive

Special advice

Baseline lipids and LFT; report unexplained muscle pain; check CK if symptomatic; avoid in pregnancy.

More from the textbook: uses, cautions and other points
Where it is discussed in the book